Pacira BioSciences, Inc. PCRX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s investing cash flow?
- Pacira BioSciences, Inc. (PCRX) reported investing cash flow of $19.44M in Q1 2026.
- How has Pacira BioSciences, Inc.'s investing cash flow changed year-over-year?
- Pacira BioSciences, Inc.'s investing cash flow increased by 175.9% year-over-year, from -$25.63M to $19.44M.
- What is the long-term trend for Pacira BioSciences, Inc.'s investing cash flow?
- Over 2 years (2023 to 2025), Pacira BioSciences, Inc.'s investing cash flow has grown at a 10.2% compound annual growth rate (CAGR), from $81.88M to $99.48M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.